Symrise (FRA:SY1) PT Set at €125.00 by Jefferies Financial Group

Symrise (FRA:SY1Get Rating) has been given a €125.00 ($135.87) price objective by Jefferies Financial Group in a research note issued on Monday, Borsen Zeitung reports. Jefferies Financial Group’s target price would suggest a potential upside of 19.05% from the company’s current price.

A number of other equities research analysts have also recently commented on the company. The Goldman Sachs Group set a €114.00 ($123.91) target price on Symrise in a research note on Tuesday, January 10th. Sanford C. Bernstein set a €110.00 ($119.57) price objective on Symrise in a report on Monday. Barclays set a €115.00 ($125.00) price objective on Symrise in a report on Friday, November 11th. JPMorgan Chase & Co. set a €110.00 ($119.57) price objective on Symrise in a report on Thursday, December 1st. Finally, UBS Group set a €122.00 ($132.61) price objective on Symrise in a report on Tuesday, January 10th.

Symrise Trading Up 0.4 %

FRA SY1 opened at €105.00 ($114.13) on Monday. Symrise has a one year low of €56.96 ($61.91) and a one year high of €73.48 ($79.87). The business’s fifty day moving average is €106.20 and its 200-day moving average is €105.36.

Symrise Company Profile

(Get Rating)

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.

Featured Stories

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.